Pesquisadores analisam como os esteroides sexuais alteram o microbioma intestinal e vaginal

Pesquisadores da Mayo Clinic e do Wellesley College se concentraram em como as interações dos esteroides nos microbiomas intestinais e vaginais influenciam a saúde da mulher em uma análise publicada na revista médica Trends in Endocrinology & Metabolism.

Investigadores analizan cómo las hormonas sexuales esteroideas cambian la microbiota intestinal y vaginal

En una revisión publicada en Tendencias en Endocrinología y Metabolismo, los investigadores de Mayo Clinic y de Wellesley College se concentraron en cómo influye sobre la salud femenina la interacción entre hormonas esteroideas, microbiota vaginal y microbiota intestinal.

Study: HPV Vaccination Will Reduce Throat and Mouth Cancers, But Overall Impact Will Take 25-Plus Years To See

Vaccinations against human papillomavirus (HPV), a major cause of throat and back of mouth cancers, are expected to yield significant reductions in the rates of these cancers in the U.S., but will not do so until after 2045, according to a new modeling study from researchers at the Johns Hopkins Bloomberg School of Public Health

Scientists Create a Labor-Saving Automated Method for Studying Electronic Health Records

Scientists at the Icahn School of Medicine at Mount Sinai described the creation of a new, automated, artificial intelligence-based algorithm that can learn to read patient data from electronic health records. In a side-by-side comparison, they showed that their method, called Phe2vec (FEE-to-vek), accurately identified patients with certain diseases as well as the traditional, “gold-standard” method, which requires much more manual labor to develop and perform

Danforth Center Announces New Principal Investigator

Tessa Burch-Smith, PhD, has joined the Danforth Center as Associate Member and Principal Investigator. Her research is focused on how plant cells communicate with each other through intercellular pores called plasmodesmata.

HSS Study Could Help Surgeons Improve Mobility Outcomes After Revision Total Knee Arthroplasty

A new study by researchers at Hospital for Special Surgery (HSS) could help physicians better manage patients who experience debilitating joint stiffness after knee replacement surgery. The study was presented today at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting.

NUS researchers develop brain-inspired memory device that can revolutionise semiconductor design

Many electronic devices today are dependent on semiconductor logic circuits based on switches hard-wired to perform predefined logic functions. Physicists from the National University of Singapore (NUS), together with an international team of researchers, have developed a novel molecular memristor, or an electronic memory device, that has exceptional memory reconfigurability.

Protein Inhibitor May Lead to New Treatment for Low Oxygen Associated with Sleep Apnea

Article title: Lysine demethylase KDM6B regulates HIF-1α mediated systemic and cellular responses to intermittent hypoxia Authors: Jayasri Nanduri, Ning Wang, Benjamin L. Wang, Nanduri R. Prabhakar From the authors: “[The] current study demonstrates that pharmacological disruption of [Hypoxia-inducible factor]-1α activation…

Exercise May Not Offset Genetic Predisposition for Low Exercise Capacity, Impaired Insulin Sensitivity

Article title: Genetically determined exercise capacity affects systemic glucose response to insulin in rats Authors: Michael Schwarzer, Annika Molis, Christina Schenkl, Andrea Schrepper, Steven L. Britton, Lauren Gerard Koch, Torsten Doenst From the authors: “In our model of [high capacity…

New study: Nursing home residents, health care workers lose more than 80% of their COVID-19 immunity six months after Pfizer vaccine

A new, multi-institutional study led by Case Western Reserve University—in partnership with Brown University—found that COVID-19 antibodies produced by the Pfizer vaccine decreased sharply in senior nursing home residents and their caregivers six months after receiving their second shots.

Researchers Discover Test to Predict Which Patients with Rare Blood Disease Will Respond to Only FDA-Approved Treatment, and Identify Alternative Therapy

New research has uncovered a precision medicine test using blood proteins to identify a novel patient subgroup of idiopathic multicentric Castleman disease (iMCD), a rare blood disorder, who are more likely to respond to siltuximab, the only FDA approved treatment for the disease.